These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 9500474

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
    Mustafi R, Cerda S, Chumsangsri A, Fichera A, Bissonnette M.
    Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of expression of PKC-alpha by antisense mRNA is associated with diminished cell growth and inhibition of amylase secretion by AR4-2J cells.
    Zhang X, Wen J, Aletta JM, Rubin RP.
    Exp Cell Res; 1997 May 25; 233(1):225-31. PubMed ID: 9184091
    [Abstract] [Full Text] [Related]

  • 5. Effects of protein kinase C alpha overexpression on A7r5 smooth muscle cell proliferation and differentiation.
    Wang S, Desai D, Wright G, Niles RM, Wright GL.
    Exp Cell Res; 1997 Oct 10; 236(1):117-26. PubMed ID: 9344591
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
    Perletti GP, Folini M, Lin HC, Mischak H, Piccinini F, Tashjian AH.
    Oncogene; 1996 Feb 15; 12(4):847-54. PubMed ID: 8632907
    [Abstract] [Full Text] [Related]

  • 7. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators.
    Cerda SR, Mustafi R, Little H, Cohen G, Khare S, Moore C, Majumder P, Bissonnette M.
    Oncogene; 2006 May 25; 25(22):3123-38. PubMed ID: 16434969
    [Abstract] [Full Text] [Related]

  • 8. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
    Wang XY, Repasky E, Liu HT.
    Exp Cell Res; 1999 Jul 10; 250(1):253-63. PubMed ID: 10388539
    [Abstract] [Full Text] [Related]

  • 9. Protein kinase C isozymes in progressively transformed rat embryo fibroblasts.
    Liao L, Ramsay K, Jaken S.
    Cell Growth Differ; 1994 Nov 10; 5(11):1185-94. PubMed ID: 7848920
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protein kinase C beta 1 and protein kinase C beta 2 activate p57 mitogen-activated protein kinase and block differentiation in colon carcinoma cells.
    Sauma S, Yan Z, Ohno S, Friedman E.
    Cell Growth Differ; 1996 May 10; 7(5):587-94. PubMed ID: 8732668
    [Abstract] [Full Text] [Related]

  • 12. Modulation of chemosensitivity in human colon carcinoma cells by downregulating protein kinase C alpha expression.
    Chakrabarty S, Huang S.
    J Exp Ther Oncol; 1996 Jul 10; 1(4):218-21. PubMed ID: 9414406
    [Abstract] [Full Text] [Related]

  • 13. Induction of a less aggressive breast cancer phenotype by protein kinase C-alpha and -beta overexpression.
    Manni A, Buckwalter E, Etindi R, Kunselman S, Rossini A, Mauger D, Dabbs D, Demers L.
    Cell Growth Differ; 1996 Sep 10; 7(9):1187-98. PubMed ID: 8877100
    [Abstract] [Full Text] [Related]

  • 14. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
    Cadoret A, Baron-Delage S, Bertrand F, Kornprost M, Groyer A, Gespach C, Capeau J, Cherqui G.
    Oncogene; 1998 Aug 20; 17(7):877-87. PubMed ID: 9780004
    [Abstract] [Full Text] [Related]

  • 15. Transformation by a ras oncogene causes increased expression of protein kinase C-alpha and decreased expression of protein kinase C-epsilon.
    Borner C, Guadagno SN, Hsieh LL, Hsiao WL, Weinstein IB.
    Cell Growth Differ; 1990 Dec 20; 1(12):653-60. PubMed ID: 2288879
    [Abstract] [Full Text] [Related]

  • 16. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.
    Ways DK, Kukoly CA, deVente J, Hooker JL, Bryant WO, Posekany KJ, Fletcher DJ, Cook PP, Parker PJ.
    J Clin Invest; 1995 Apr 20; 95(4):1906-15. PubMed ID: 7706498
    [Abstract] [Full Text] [Related]

  • 17. Directed antisense therapy confirms the role of protein kinase C-alpha in the tumorigenicity of pancreatic cancer.
    Denham DW, Franz MG, Denham W, Zervos EE, Gower WR, Rosemurgy AS, Norman J.
    Surgery; 1998 Aug 20; 124(2):218-23; discussion 223-4. PubMed ID: 9706141
    [Abstract] [Full Text] [Related]

  • 18. Protein kinase C isoform expression during the differentiation of 3T3-L1 preadipocytes: loss of protein kinase C-alpha isoform correlates with loss of phorbol 12-myristate 13-acetate activation of nuclear factor kappaB and acquisition of the adipocyte phenotype.
    McGowan K, DeVente J, Carey JO, Ways DK, Pekala PH.
    J Cell Physiol; 1996 Apr 20; 167(1):113-20. PubMed ID: 8698828
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K, Kawamata H, Hino S, Uchida D, Miwa Y, Hamano H, Omotehara F, Yoshida H, Sato M.
    Cancer Res; 1998 Feb 01; 58(3):549-55. PubMed ID: 9458104
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
    Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nicklin P, Meister L, Ziel R, Geiger T, Muller M, Fabbro D.
    Cancer Res; 1996 Aug 01; 56(15):3499-507. PubMed ID: 8758918
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.